Viewing nowCombinationTelmipham Tablets 40/10 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Daewon Biotech Co., Ltd.

MFDS item code 201908432 · Approved 2019.12.16 · Insurance code 057600430
Treatment of essential hypertension not controlled with monotherapy
In patients with essential hypertension, when blood pressure control is insufficient with monotherapy of amlodipine or telmisartan, this medication aids in more effectively managing blood pressure. It helps maintain stable blood pressure, reducing the burden on the heart and blood vessels, and lowering the risk of complications caused by hypertension. It plays a role in helping to maintain healthy blood pressure by providing appropriate blood pressure control tailored to the patient's condition. This medication is effectively used in the treatment of essential hypertension.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, switching directly to this medicine may be considered when blood pressure is not controlled with an individual component, as follows: - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, so it should not be taken by women who are pregnant or may become pregnant. This medication is contraindicated in patients with certain conditions. For example, individuals allergic to any component of this medication, those with severe liver impairment, severe hypotension, certain heart-related diseases, and women who are pregnant or nursing should not take this medication. Additionally, patients with primary hyperaldosteronism, certain heart valve diseases, liver disorders, gastrointestinal diseases, renal artery hypertension, dialysis patients, and elderly individuals should use this medication cautiously, ensuring appropriate dose adjustments and monitoring under medical supervision. The most common side effects when taking this medication include dizziness and peripheral edema, and serious side effects can occur rarely, so if any unusual symptoms arise, consult a healthcare professional immediately. This medication should be avoided during pregnancy, and if pregnancy is confirmed, it should be discontinued immediately and replaced with a safer treatment option. This medication lowers blood pressure; therefore, if hypotension occurs, the patient may need to be laid down, and fluid therapy may be required. There is a risk of increased potassium levels in the blood, so patients with poor renal function or heart failure should undergo regular blood tests to monitor potassium levels. Patients with impaired renal function may experience changes in kidney function while taking this medication, so regular kidney function tests are recommended. Patients with heart diseases should be cautious as this medication may worsen myocardial infarction or angina. This medication can cause drowsiness or dizziness; therefore, caution is needed when driving or operating hazardous machinery. Drug interactions may occur when taken with other antihypertensives or specific medications, so inform your healthcare provider of any other medications being taken. Nursing mothers should refrain from using this medication, and patients with certain genetic disorders due to excipients in this medication should also avoid taking it. In cases of overdose, symptoms such as hypotension, dizziness, and heart rhythm disturbances may occur, requiring immediate medical attention. The safety and effectiveness of this medication have not been sufficiently established in children, so its use is not recommended. Elderly individuals may be more sensitive to this medication, so doses should be carefully adjusted and monitored.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a container that protects it from light and air, ideally at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness and prevents degradation.
It is a biconvex oval double tablet that is white and light gray.
30 tablets/box [10 tablets/PTPX3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Daewon Biotech Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.